2μg (R: reducing condition, N:non-reducing condition).
Product Details
Product Details
Product Specification
| Species | Human |
| Synonyms | IL-2 receptor subunit gamma, IL2RG |
| Accession | P31785-1 |
| Amino Acid Sequence | Leu23-Asn254 with hIgG Fc&Avi Tag at the C-Terminus |
| Expression System | HEK293 |
| Molecular Weight | 70-100kDa (Reducing) |
| Purity | >95% by SDS-PAGE&HPLC |
| Conjugation | Biotin |
| Tag | Human IgG1 Fc, Avi Tag |
| Physical Appearance | Lyophilized powder |
| Storage Buffer | PBS, pH7.4, 5% trehalose |
| Reconstitution | Reconstitute at 0.1-1 mg/ml according to the size in ultrapure water after rapid centrifugation. |
| Stability & Storage | · 12 months from date of receipt, lyophilized powder stored at -20 to -80℃. |
| Reference | 1.Kim JY, Mayatepek E, Seyfarth J, Jacobsen M. High common-γ cytokine receptor levels promote expression of Interleukin-2/Interleukin-7 receptor α-chains with implications on T-cell differentiation and function. Immunology. 2024 Sep;173(1):93-105. |
Background
IL-2 Rγ/CD132 is a transmembrane protein belonging to the type I cytokine receptor family, characterized by a highly conserved extracellular WSXWS motif, a transmembrane region, and an intracellular domain containing Box1/Box2 motifs. It serves as the shared signaling chain for six cytokines: IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Through its intracellular domain, it couples with signaling molecules such as JAK3 and STAT5, playing an indispensable core role in T/NK cell development, lymphocyte homeostasis, and immune regulation. The clinical significance of this molecule is substantial—mutations in its gene cause X-linked severe combined immunodeficiency (X-SCID). Therapeutic strategies targeting this molecule have been translated in three key ways: gene therapy encoding γc (e.g., Strimvelis) has received clinical approval; CD132-targeting bispecific antibodies selectively activate the common receptor complex within the tumor microenvironment to achieve anti-tumor immunity while avoiding systemic toxicity; and engineered IL-2/antibody biased complexes modulate CD132-dependent signaling preferences to expand regulatory T cells for transplant tolerance and autoimmune disease treatment.
Picture
Picture
SDS-PAGE
SEC-HPLC
The purity of Biotinylated IL-2R gamma/CD132 Fc&Avi Tag Protein, Human is more than 95% determined by SEC-HPLC.
